Argus Investors' Counsel, Inc. Johnson & Johnson Transaction History

Argus Investors' Counsel, Inc.

$148 Million
Q3 2024

A detailed history of Argus Investors' Counsel, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 6,801 shares of JNJ stock, worth $1.06 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

6,801

Previous 8,895 23.54%

Holding current value

$1.06 Million

Previous $1.3 Million 15.23%

% of portfolio

0.74%

Previous 0.81%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$145.48 - $167.38 $304,635 - $350,493	-2,094 Reduced 23.54%	6,801 $1.1 Million
Q2 2024 Jul 22, 2024	BUY	$144.38 - $157.78 $1.28 Million - $1.4 Million	8,895 New	8,895 $1.3 Million
Q1 2024 Apr 24, 2024	BUY	$155.22 - $162.74 $88,785 - $93,087	572 Added 6.09%	9,964 $1.58 Million
Q4 2023 Jan 26, 2024	BUY	$145.6 - $158.88 $1,019 - $1,112	7 Added 0.07%	9,392 $1.47 Million
Q4 2023 Jan 19, 2024	BUY	$145.6 - $158.88 $11,211 - $12,233	77 Added 0.83%	9,385 $1.47 Million
Q3 2023 Oct 17, 2023	SELL	$155.75 - $174.48 $51,397 - $57,578	-330 Reduced 3.42%	9,308 $1.45 Million
Q2 2023 Jul 20, 2023	BUY	$154.35 - $166.11 $66,370 - $71,427	430 Added 4.67%	9,638 $1.6 Million
Q1 2023 Apr 20, 2023	BUY	$151.05 - $180.26 $71,295 - $85,082	472 Added 5.4%	9,208 $1.43 Million
Q3 2022 Oct 18, 2022	SELL	$161.33 - $179.52 $354,926 - $394,944	-2,200 Reduced 20.12%	8,736 $1.43 Million
Q2 2022 Jul 22, 2022	BUY	$168.19 - $186.01 $10,259 - $11,346	61 Added 0.56%	10,936 $1.94 Million
Q1 2022 May 04, 2022	SELL	$158.14 - $179.59 $158,298 - $179,769	-1,001 Reduced 8.43%	10,875 $1.93 Million
Q4 2021 Jan 25, 2022	SELL	$155.93 - $173.01 $894,570 - $992,558	-5,737 Reduced 32.57%	11,876 $2.03 Million
Q3 2021 Oct 20, 2021	SELL	$161.5 - $179.47 $1.31 Million - $1.46 Million	-8,136 Reduced 31.6%	17,613 $2.84 Million
Q2 2021 Jul 30, 2021	SELL	$159.48 - $171.07 $405,717 - $435,202	-2,544 Reduced 8.99%	25,749 $4.24 Million
Q1 2021 Apr 19, 2021	BUY	$153.07 - $170.48 $639,526 - $712,265	4,178 Added 17.33%	28,293 $4.65 Million
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $688,977 - $790,834	-5,025 Reduced 17.24%	24,115 $3.8 Million
Q3 2020 Oct 30, 2020	BUY	$140.38 - $153.83 $252,684 - $276,894	1,800 Added 6.58%	29,140 $4.34 Million
Q2 2020 Jul 27, 2020	SELL	$128.81 - $155.51 $141,691 - $171,061	-1,100 Reduced 3.87%	27,340 $3.85 Million
Q1 2020 Apr 24, 2020	SELL	$111.14 - $153.99 $77,798 - $107,793	-700 Reduced 2.4%	28,440 $3.73 Million
Q4 2019 Jan 17, 2020	SELL	$127.5 - $146.44 $28,687 - $32,949	-225 Reduced 0.77%	29,140 $4.25 Million
Q2 2019 Jul 10, 2019	BUY	$131.15 - $144.24 $3.79 Million - $4.16 Million	28,865 Added 96.65%	58,730 $8.18 Million
Q2 2019 Jul 10, 2019	SELL	$131.15 - $144.24 $3.85 Million - $4.24 Million	-29,365 Reduced 50.0%	29,365 $4.09 Million
Q4 2018 Feb 06, 2019	SELL	$122.84 - $147.84 $307,100 - $369,600	-2,500 Reduced 7.72%	29,865 $3.85 Million
Q3 2018 Oct 16, 2018	SELL	$121.58 - $142.88 $335,439 - $394,205	-2,759 Reduced 7.86%	32,365 $0
Q2 2018 Jul 19, 2018	BUY	$119.4 - $131.76 $471,749 - $520,583	3,951 Added 12.67%	35,124 $4.26 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $100,455 - $118,956	803 Added 2.64%	31,173 $4.05 Million
Q4 2017 Jan 23, 2018	SELL	$131.22 - $143.62 $105,369 - $115,326	-803 Reduced 2.58%	30,370 $4.24 Million
Q3 2017 Oct 06, 2017	BUY	$129.47 - $135.38 $4.04 Million - $4.22 Million	31,173	31,173 $4.05 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.

Account

Argus Investors' Counsel, Inc. Johnson & Johnson Transaction History